Newsfeeds - Spark Newswire

1 minute read

News

Ocuphire Shares Spike Higher After Hours; Two Presentations from Conferences in July Posted on Reuters Just Ahead of the Close

Today, 7:21 PM

https://d1io3yog0oux5.cloudfront.net/_ed081eb758954a15cc7723487657ed6f/ocuphire/db/357/3649/pdf/ASCRS+2021+VEGA-1+Presentation_FINAL.pdf https://d1io3yog0oux5.cloudfront.net/_ed081eb758954a15cc7723487657ed6f/ocuphire/db/357/3650/pdf/ASCRS+2021+MIRA-2+PresentationFinal.pdf

OCUP

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights

Today, 7:21 PM

Gainers

ENDP

6 minute read

72 Biggest Movers From Yesterday

By Lisa Levin

Today, 7:21 PM

Gainers Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 405% to close at $30.30 on Wednesday after the company priced its IPO at $6 per share.

ALT

5 minute read

51 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 7:21 PM

Gainers

ALT

1 minute read

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights

Today, 7:21 PM

ALPN

4 minute read

Ocuphire Announces VEGA-1 Phase 2 Trial In Presbyopia Meets Primary And Secondary Endpoints

By Bill Haddad

Today, 7:21 PM

Met primary endpoint with statistical significance at 1 hour with 61% of subjects treated with Nyxol® plus low-dose pilocarpine (LDP) gaining ≥ 15 letters (3 lines) in near

OCUP

4 minute read

The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus

By Shanthi Rexaline

Today, 7:21 PM

Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment.

AFMD

1 minute read

Processa Pharmaceuticals In-Licenses Ocuphire’s Anticancer Agent

By Vandana Singh

Today, 7:21 PM

Processa Pharmaceuticals Inc (NASDAQ:PCSA) has entered into a licensing agreement with Ocuphire Pharma Inc (NASDAQ:OCUP) to in-license RX-3117. RX-3117 is an oral anticancer…

OCUP

1 minute read

News

Ocuphire Announces Addition To Russell Microcap Index

By Bill Haddad

Today, 7:21 PM

Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on development and commercialization of therapies for the treatment of several eye disorders, today announced that the

OCUP

1 minute read

Ocuphire Announces $15M Registered Direct Offering Of 3.076M Shares Priced At-the-Market

By Benzinga Newsdesk

Today, 7:21 PM

Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, today announced it has entered

OCUP